Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites
about
Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organellesMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaPlasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondiiMeasurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed populationSafety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaquesHumoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult MaliansSafety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialThe relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasionPhase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malariaposttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assaysLack of allele-specific efficacy of a bivalent AMA1 malaria vaccineIsolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.Juxtamembrane shedding of Plasmodium falciparum AMA1 is sequence independent and essential, and helps evade invasion-inhibitory antibodiesAdvances and challenges in malaria vaccine development.Transcriptome sequencing and analysis of Plasmodium gallinaceum reveals polymorphisms and selection on the apical membrane antigen-1.Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.Proteases in host cell invasion by the malaria parasite.Structural basis of antigenic escape of a malaria vaccine candidatePopulation genetic structure and natural selection of apical membrane antigen-1 in Plasmodium vivax Korean isolatesIn immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune responseOral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trialHCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa.Genetic diversity of the Plasmodium falciparum apical membrane antigen I gene in parasite population from the China-Myanmar border areaBabesia divergens apical membrane antigen 1 and its interaction with the human red blood cell.Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1.
P2860
Q24814719-AF7D9126-1ADF-451D-A958-910112760874Q26772878-41FD605A-445D-4845-8951-B04EEA136ABEQ27972559-2192A731-BB91-4050-8763-5A7DB23154F4Q28730794-4D9B1D7E-495E-4DB6-8D01-BF0E0801B9BDQ28742239-79417A0B-D3ED-49F7-B51B-8AC5190DDE2EQ30942598-01188726-FC68-4714-8F66-6DD07D40E0CAQ33223740-B8B4C94E-3130-4AE8-91BC-8F83548547D2Q33302903-EF2647B9-BD1B-4EAB-ADB1-9066C5D730BAQ33316023-BB6DFD04-B9A6-4ADA-9D74-8C5F2C58AFB6Q33526349-0453FE0C-0AF6-4B99-BBA7-994E76ECE0ABQ33530106-D0F83D53-35B9-43DA-ADBF-87F947A123A2Q33761687-C01C643C-8425-44B7-B14B-1992F64EE021Q33788306-1FE00AC3-C641-4942-9FA8-4FCD3D786F26Q33883252-7B7C7ADE-B3E4-4E74-9887-97B781098ABCQ33905364-235B3807-045B-4EE3-8402-56636FE2D2E9Q33939405-7F6FDD46-3404-481A-A6CF-10521CC254A8Q33939788-56AF7783-E6FF-4056-89D8-9579EFA3AA06Q34011922-E9C625EE-BA3D-4F98-8108-0DF5FA25DECEQ34069682-72081586-F699-4C95-8B12-B45F048506F5Q34109788-4B10B889-7D51-49F8-8059-4B63CE447F14Q34145333-DD0518A1-DD9B-484C-A396-7D2D3383B0B1Q34278814-23D3DA61-BA65-44B0-AFA5-45B42B5ED7E1Q34301073-C3312729-7150-404C-8E49-04AB3FA37768Q34416263-49C06351-12F2-4964-A208-EA2C28211F7DQ34547148-47B65FAA-DCE8-4452-AE0B-54A7BD8788EDQ34680704-FBA85357-43C0-4FA0-B7B8-F5277B8B782CQ35079832-A0DA46F0-5075-4BA0-8121-E9DFE6897272Q35805390-9EAE3DEA-DAA4-44CF-B0CD-6F3175BF3523Q35875731-2118C266-6154-4931-A451-DD1D5F0F9A22Q35927982-952DCB2D-B182-4E5B-A0AB-3E0A0E2F235BQ36286806-8E41263E-830E-48CD-B71F-125421E7881FQ36314049-1A1BE466-13A9-47B8-85C1-350F6793FF5CQ36396844-006669ED-C35B-4FED-BB80-E12A38ACFD13Q36446656-EAB8C25A-A1C0-4796-9758-93518FF01E34Q36640081-F8B8BC90-9F84-4CE5-AAA2-591CE826B54EQ37253541-A4FCD53E-50DB-461F-BFE9-0F53EADBCA93Q37264535-10F2BB8D-0950-4077-A22D-441DBE4E34EAQ37348151-4CBC9B76-5EF4-4564-A77E-855605E81A3AQ37410331-C9AC4461-7A79-49A3-9F15-1A4B30960CAFQ37427474-AACDB6CA-BF77-4491-92D2-F8FEBBB5F6F3
P2860
Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@ast
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@en
type
label
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@ast
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@en
prefLabel
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@ast
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@en
P2093
P2860
P921
P356
P1476
Invasion-inhibitory antibodies ...... asmodium falciparum merozoites
@en
P2093
David E Lanar
J David Haynes
J Kathleen Moch
Sheetij Dutta
P2860
P304
12295-12300
P356
10.1073/PNAS.2032858100
P407
P577
2003-10-02T00:00:00Z